Elodie Odore
Hôpital René Huguenin(FR)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways, HIV/AIDS drug development and treatment
Most-Cited Works
- → OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models(2016)150 cited
- → The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus(2016)92 cited
- → Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies(2015)92 cited
- → OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations(2016)58 cited
- → Abstract CT231: BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies(2014)31 cited
- → Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strongin vivoantitumor activity in lymphoma(2016)25 cited
- → Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models(2019)12 cited
- → Development and validation of an UPLC-MS/MS method for quantitative analysis of OTX015 in human plasma samples(2014)9 cited
- → Synthesis, characterization and solubility of mixed zirconium-cerium molybdate precipitates(2018)5 cited
- → 587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines(2014)2 cited